Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Blue Cap
- Development stage
- Unknown
- Lead developer
- Catalysis
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
**Blue Cap** is a Catalysis topical dermatology product line whose studied foam formulation contains activated piroctone olamine. In the registered pediatric atopic dermatitis study, Blue Cap Foam was applied twice daily for 30 days to affected skin. Piroctone olamine is an antimicrobial and antifungal hydroxypyridone compound used in topical products for inflammatory and scaling dermatoses; Blue Cap products have also been described for seborrheic dermatitis, psoriasis, xerosis, and eczema. The name Blue Cap encompasses multiple topical formulations, including foam, cream, spray, and shampoo.
- Brand names
- Blue Cap
Beyond the preview
Go deeper on Blue Cap.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Blue Cap.